DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Arena Pharmaceuticals, Inc. (ARNA)
« Back to company indexARNA Chatter Timeline
Stock Ticker for ARNA
Most Active Tweeters for ARNA
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @TickerReport | 3 |
| @WeekHerald | 2 |
| @ConsumerFeed | 2 |
| @EnterpriseLeade | 2 |
Recent Tweets for ARNA
 |
@Tickeron $ARNA's 10-day Moving Average moved below its 50-day Moving Average on August 13, 2019. View odds for this and othe… https://t.co/kA7w7ceKyU 2:09pm |
|
@Tickeron $ARNA's 10-day Moving Average broke below its 50-day Moving Average on August 13, 2019. View odds for this and othe… https://t.co/oLNIDd8tMv 3:09am |
 |
@StockWatchHQ RT @StockWatchHQ: Arena Pharmaceuticals $ARNA In Secret Discussions With Pfizer $PFE At InterContinental New York Barclay In NYC https://t.… 12:09am |
|
@StockWatchHQ Arena Pharmaceuticals $ARNA In Secret Discussions With Pfizer $PFE At InterContinental New York Barclay In NYC… https://t.co/uqdfUMvy3a September 15th 2019, 2:09pm |
 |
@registrarjourn ValuEngine Lowers Arena Pharmaceuticals $ARNA to Strong Sell https://t.co/QKncmTAbVd September 14th 2019, 5:09am |
 |
@EnterpriseLeade ValuEngine Lowers Arena Pharmaceuticals $ARNA to Strong Sell https://t.co/U8ZNPwb2yk September 14th 2019, 5:09am |
|
@Tickeron $ARNA enters a Downtrend because Momentum Indicator dropped below the 0 level on September 12, 2019. View odds for… https://t.co/rhaZkCK5It September 13th 2019, 5:09pm |
 |
@WeekHerald Arena Pharmaceuticals $ARNA Downgraded by ValuEngine https://t.co/y3PXky2yYN September 13th 2019, 7:09am |
 |
@dispatchtribune Arena Pharmaceuticals $ARNA Downgraded by ValuEngine https://t.co/ReNkZC7GF6 September 13th 2019, 7:09am |
 |
@OlympiaReport Arena Pharmaceuticals $ARNA Stock Rating Lowered by ValuEngine https://t.co/cK3q8B5pff September 13th 2019, 7:09am |
 |
@TickerReport Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells $1,595,499.04 in Stock https://t.co/Ux1NpOxfYN September 13th 2019, 4:09am |
|
@TickerReport Arena Pharmaceuticals, Inc. $ARNA VP Sells $3,296,800.00 in Stock https://t.co/ANFx6gNVgP September 13th 2019, 4:09am |
|
@Tickeron $ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/T8tXchY9q7 September 12th 2019, 2:09pm |
|
@TickerReport Arena Pharmaceuticals $ARNA Stock Rating Lowered by ValuEngine https://t.co/PllOblQvmj September 12th 2019, 11:09am |
 |
@Gambiste1 RT @SeekingAlpha: $ARNA - Arena Pharmaceuticals' (ARNA) Management Presents at Wells Fargo Global Healthcare Conference 2019 (Transcript) h… September 12th 2019, 12:09am |
 |
@panda317 @twolfcon No $ARNA just Good stuff like $CBL September 11th 2019, 10:09pm |
|
@Tickeron $ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/XpcMslddbq September 11th 2019, 3:09pm |
 |
@InsiderAlertsIA $ARNA: New Insider Filing on EVP, General Counsel & Sec STEVEN W SPECTOR: https://t.co/4Tnpz3AlhJ September 11th 2019, 10:09am |
 |
@ConsumerFeed Arena Pharmaceuticals EVP Steven Spector Sells $1,595,499.04 in $ARNA https://t.co/lnrNkyADZv September 11th 2019, 3:09am |
|
@ConsumerFeed Arena Pharmaceuticals VP Vincent Aurentz Sells $3,296,800.00 in $ARNA https://t.co/984CsOokWN September 11th 2019, 3:09am |
|
@dispatchtribune Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells 31,457 Shares of Stock https://t.co/sI3fQXORO1 September 10th 2019, 11:09pm |
|
@OlympiaReport Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells 31,457 Shares of Stock https://t.co/br24jFGKrr September 10th 2019, 11:09pm |
 |
@ThisLincolnian Arena Pharmaceuticals, Inc. $ARNA VP Vincent Aurentz Sells 65,000 Shares https://t.co/32v3ScDB4i September 10th 2019, 11:09pm |
 |
@AmericanBanking Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells 31,457 Shares of Stock https://t.co/OwD14dSGwL #stocks September 10th 2019, 11:09pm |
|
@AmericanBanking Insider Selling: Arena Pharmaceuticals, Inc. $ARNA VP Sells 65,000 Shares of Stock https://t.co/frA4cvApwq #stocks September 10th 2019, 11:09pm |
|
@registrarjourn Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells 31,457 Shares of Stock https://t.co/3ukrJBRfER September 10th 2019, 11:09pm |
|
@EnterpriseLeade Insider Selling: Arena Pharmaceuticals, Inc. $ARNA EVP Sells 31,457 Shares of Stock https://t.co/xyGYFD0AhC September 10th 2019, 11:09pm |
|
@WeekHerald Insider Selling: Arena Pharmaceuticals, Inc. $ARNA VP Sells 65,000 Shares of Stock https://t.co/u1IMmrnkEk September 10th 2019, 11:09pm |
 |
@StockTexts $ARNA Arena Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/gY8ePOSEEy September 10th 2019, 10:09pm |
 |
@insiderbuyings $ARNA new insider selling: 65000 shares. https://t.co/GqzV8Ue83A September 10th 2019, 9:09pm |
 |
@confcalltran Arena Pharmaceuticals's Executive VP and CBO just cashed-in 65,000 options https://t.co/8zRVbyx3Q9 $ARNA September 10th 2019, 9:09pm |
|
@StockTexts $ARNA Arena Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/fkJIwLN2lq September 10th 2019, 9:09pm |
|
@confcalltran EVP of Arena Pharmaceuticals just disposed of 10,000 shares https://t.co/hQkHaeDW7A $ARNA September 10th 2019, 9:09pm |
|
@Gambiste1 RT @kbertolini: $ARNA nice divergence throwback https://t.co/KEXehQzs24 September 10th 2019, 5:09pm |
 |
@kbertolini $ARNA nice divergence throwback https://t.co/KEXehQzs24 September 10th 2019, 4:09pm |
|
@Tickeron $ARNA in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on February 5, 2019. View odds for thi… https://t.co/k625iz2a5V September 10th 2019, 3:09pm |
|
@Tickeron $ARNA in Uptrend: 50-day Moving Average moved above 200-day Moving Average on February 5, 2019. View odds for this… https://t.co/VVGRdTCXXM September 9th 2019, 2:09pm |
 |
@LifeSciAdvisors Arena Pharmaceuticals $ARNA Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Ne… https://t.co/dJzSdBcoY7 September 9th 2019, 12:09pm |
 |
@newswithvalue $ARNA: Arena Pharmaceuticals Presented New Patient-Reported Outcomes …: https://t.co/VSxFV1TnjR September 9th 2019, 8:09am |
 |
@VisualStockRSRC $ARNA - Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society https://t.co/XPXPUlAzl6 September 9th 2019, 8:09am |
|
@Tickeron $ARNA in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on February 5, 2019. View odds for thi… https://t.co/3KntOzOIFu September 8th 2019, 1:09pm |
|
@Tickeron $ARNA in Uptrend: 50-day Moving Average broke above 200-day Moving Average on February 5, 2019. View odds for this… https://t.co/0QP3gjSwqG September 7th 2019, 2:09pm |
 |
@ChartMill Not too expensive and growing strongly: check out $ARNA, now part of our affordable growth selection.… https://t.co/iFHkmiOYJi August 11th 2019, 8:08pm |
 |
@bbnsnews Arena Pharmaceuticals, Inc. $ARNA Receives $65.50 Consensus Target Price from Brokerages https://t.co/fjf75UQJy2 August 11th 2019, 7:08pm |
 |
@JonathanWexler3 @SharonAConklin @Adrian_H Especially when $ARNA missed the FDA approvable endpoint for PAH drugs in Phase 2 (FEV1 i… https://t.co/Qx3xsNIJxX August 11th 2019, 5:08pm |
 |
@TheMarketsDaily Arena Pharmaceuticals $ARNA Shares Gap Down to $56.18 https://t.co/bkwZrBa6WW August 11th 2019, 1:08pm |
 |
@macondailynews Arena Pharmaceuticals $ARNA Shares Gap Down to $56.18 https://t.co/wOtHays0cH August 11th 2019, 1:08pm |
|
@bbnsnews Arena Pharmaceuticals $ARNA Lowered to “Sell” at ValuEngine https://t.co/lwC83rlnom August 11th 2019, 1:08pm |
|
@AmericanBanking Royal Bank of Canada Reaffirms “Buy” Rating for Arena Pharmaceuticals $ARNA https://t.co/DtSwQycDcE #stocks August 11th 2019, 12:08pm |
|
@Tickeron $ARNA's price moved below its 50-day Moving Average on August 8, 2019. View odds for this and other indicators:… https://t.co/K6pzXmxuCV August 11th 2019, 12:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.